COUNCIL ON RADIONUCLIDES AND RADIO… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1993

Legal Domicile

Principal Officer

JAMES HARVEY

Phone

2025476582

Tax Period

2024-01-01 to 2024-12-31

COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS INC, founded in 1993, is a community nonprofit that reported $1.0M in total revenue in fiscal year 2024. Expenses of $951K left a modest 8% surplus.

Mission

CORAR IS THE TRADE ASSOCIATION AND VOICE OF THE RADIONUCLIDES AND RADIOPHARMACEUTICALS INDUSTRY IN NORTH AMERICA. CORAR ADVOCATES FOR PUBLIC POLICIES THAT IMPACT HEALTH CARE, TRANSPORTATION SAFETY, HOMELAND SECURITY, AND MANUFACTURING IN AN EFFORT TO EXPAND ACCESS TO SAFE AND AFFORDABLE HEALTH CARE TREATMENTS FOR ALL.

Program Service Accomplishments

Program 1

MONITORED, REPRESENTED, AND ASSISTED PROCATIVELY IN REGULATORY AND LEGISLATIVE PROCESSES AT ALL GOVERNMENT LEVELS THAT ENSURE REASONABLE REGULATIONS AND LEGISLATION ON THE DEVELOPMENT, MANUFACTURE...

MONITORED, REPRESENTED, AND ASSISTED PROCATIVELY IN REGULATORY AND LEGISLATIVE PROCESSES AT ALL GOVERNMENT LEVELS THAT ENSURE REASONABLE REGULATIONS AND LEGISLATION ON THE DEVELOPMENT, MANUFACTURE, TRANSPORTATION, USE, SERVICE, AND DISPOSAL OF RADIOACTIVE PRODUCTS USED IN MEDICINE AND THE LIFE SCIENCES. PROMOTED AWARENESS OF THE BENEFITS OF SUCH PRODUCTS AND SERVICES TO LEGISLATORS AND REGULATORS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $987,411

Investment Income $49,213

Other Revenue $1,024

TOTAL REVENUE $1,037,648

Expense Breakdown

Grants Paid $6,000

Salaries & Benefits $260,040

Fundraising Expenses $0

Other Expenses $685,107

TOTAL EXPENSES $951,147

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,037,648	$1,068,092	0.0%
Expenses	$951,147	$944,251	+0.0%
Net Income	$86,501	$123,841	-0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$260,040

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOHN WIGGINS	CHAIRMAN	1.00	Officer Director	$0	$0	$0
DAVID PELLICCIARINI	VICE CHAIRMAN	1.00	Officer Director	$0	$0	$0
JAMES HARVEY	SECRETARY/TREASURER	1.00	Officer Director	$0	$0	$0
SHAEMUS GLEASON	DIRECTOR	1.00	Director	$0	$0	$0
SHAHE BAGERDJIAN	DIRECTOR	1.00	Director	$0	$0	$0
ROHAN JAIN	DIRECTOR	1.00	Director	$0	$0	$0
MICHAEL PINTEK	DIRECTOR	1.00	Director	$0	$0	$0
JIM WILSON	DIRECTOR	1.00	Director	$0	$0	$0
CHRIS WAGNER	DIRECTOR	1.00	Director	$0	$0	$0
JAY SIMON	DIRECTOR	1.00	Director	$0	$0	$0
VITTORIO PUPPO	DIRECTOR	1.00	Director	$0	$0	$0
IRA GOLDMAN	DIRECTOR	1.00	Director	$0	$0	$0
ROGER ESTAFANOS	DIRECTOR	1.00	Director	$0	$0	$0
SCOTT CLAUNCH	DIRECTOR	1.00	Director	$0	$0	$0
WAYNE MULLET	DIRECTOR	1.00	Director	$0	$0	$0
ERIC SCHUTT	DIRECTOR	1.00	Director	$0	$0	$0
GEOFF TOWLE	DIRECTOR	1.00	Director	$0	$0	$0
CAMPBELLE MONGILIA	DIRECTOR	1.00	Director	$0	$0	$0
PATRICK SMITH	DIRECTOR	1.00	Director	$0	$0	$0
ROY BROWN	DIRECTOR	1.00	Director	$0	$0	$0
SHANE COBB	DIRECTOR	1.00	Director	$0	$0	$0
JAMES COOK	DIRECTOR	1.00	Director	$0	$0	$0
MICHAEL GUASTELLA	EXECUTIVE DIRECTOR	40.00	Officer	$260,040	$0	$260,040

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,037,648	$951,147	$2,200,649	$86,501
2023	$1,068,092	$944,251	$2,091,287	$123,841
2022	$899,428	$875,782	$1,555,856	$23,646
2021	$989,049	$910,430	$1,512,652	$78,619
2020	$1,019,441	$816,406	$1,718,055	$203,035
2019	$1,008,045	$853,193	$1,413,256	$154,852
2018	$1,035,603	$967,805	$1,035,669	$67,798

COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS INC